Managing Self-funded Risk

Sun Life 2026 High-cost claims and injectable drug trends analysis

Join Sun Life leaders on June 4 to unpack what our latest claims data reveals about high-cost claim conditions, million-dollar+ volatility, and injectable drug spend, and what it means for self-funded planning.

Register here

Managing Self-funded Risk

2024 Updates and 2023 Year in Review on Leave and Accommodations Webinar

February 28, 2024

Watch Marjory Robertson, AVP & Senior Counsel, Sun Life and Abigail O’Connell, Senior Counsel, Sun Life, for  a recap of 2023 legal and compliance developments related to leave and accommodation law. 

2023 Updates on Leave and Accommodation laws

September 20, 2023

Watch as Marjory Robertson, AVP & Senior Counsel, Sun Life U.S. and Abigail O’Connell, Senior Counsel, recap the latest 2023 leave and accommodation-related compliance developments. 

2023 High-cost claims and injectable drug trends analysis

May 17, 2023

For the past eleven years, Sun Life has shared our data and insights with the self-funded marketplace to help employers and brokers understand trends around the highest-cost claims.

Introduction to Gene Therapies (3rd edition)

February 06, 2023

Learn more about recently approved Hemgenix in the treatment of Hemophilia B, the gene therapy pipeline, the approval process, and what gene therapies are, in our second edition of the Introduction to Gene Therapies paper.

2022 Sun Life Stop-Loss Research Report: High-cost claims and injectable drug trends analysis

June 22, 2022

For the past ten years, Sun Life has shared our data and insights with the self-funded marketplace to help employers and brokers understand trends around the highest-cost claims.

Webinar: 2022 High-cost claims and injectable drug trends analysis

June 08, 2022

A presentation and panel discussion on our high-cost claims and injectable drug trends analysis with insights on top claim conditions, million-dollar claims, injectable drugs, and trends we are seeing since the COVID-19 pandemic began.